meta_pixel
Tapesearch Logo
Log in
Science Friday

Coronavirus And Schools, New Mars Rover. July 17, 2020, Part 1

Science Friday

Science Friday and WNYC Studios

Science, Life Sciences, Wnyc, Natural Sciences, Friday

4.46.3K Ratings

🗓️ 17 July 2020

⏱️ 47 minutes

🧾️ Download transcript

Summary

As we approach August, many of our young listeners and their parents are starting to think about going back to school. Usually, that might mean getting new notebooks and pencils, and the excitement of seeing classmates after a summer apart. But COVID-19 makes this upcoming school year different. Big districts, including Los Angeles and San Diego public schools, will be completely remote this fall. Other districts are looking at hybrid programs, with some time in the classroom and some at home. Still others want kids to return to the classroom full-time. The Centers for Disease Control and Prevention says schools should adjust plans based on how many coronavirus cases are in the community. Schools with little transmission may be able to go back to the classroom, but with more sanitation efforts and no sports events. For communities with high levels of spread, the CDC says stronger measures are needed, like staggered arrivals and dismissals, kids staying in one classroom, or all-remote education. However, Vice President Mike Pence said this week that CDC guidance should not dictate whether schools open for in-classroom instruction. Joining Ira to talk about what to consider in back-to-school plans are Pedro Noguera, dean of the Rossier School of Education at the University of Southern California in Los Angeles, and Laura Fuchs, a high school history teacher and secretary of the Washington Teachers’ Union in Washington, D.C. In just a few weeks, NASA is scheduled to launch its newest rover in the direction of Mars. Perseverance, the formal name for the Mars 2020 mission’s rover, is now safely at Cape Canaveral, strapped to its Atlas V rocket, waiting only for the launch window to open. If all goes well, Perseverance will begin roving Mars next February. Once on Mars, it will join its cousin Curiosity in combing through the dust and rocks of the red planet—but where Curiosity hunts inside a meteor crater for water and other signs of suitability for life, Perseverance will scour an ancient river delta for the traces left by potential microscopic life. Ira talks to two Perseverance masterminds, deputy project scientist Katie Stack Morgan and aerospace engineer Diana Trujillo, about the challenges of building for space exploration, and what it takes to conduct science experiments 70 million miles from Earth.

Transcript

Click on a timestamp to play from that location

0:00.0

This is Science Friday. I'm Ira Plato. A bit later in the hour, we're going to talk about

0:06.0

back to school, what it might look like for K-12 students this fall. Some districts are

0:11.8

releasing their plans, and they all look a little bit different. But first, one big question about

0:17.5

this pandemic is how long will it take to develop a COVID-19 vaccine?

0:22.9

There are lots of candidates and clinical trials happening.

0:26.6

The National Institutes of Health is running a trial created by the company Moderna.

0:31.5

The results were published this week in the New England Journal of Medicine.

0:35.2

Here to give us an update on that vaccine trial and

0:38.4

other science headlines from the week is Annalie Newitz, science writer and author based out

0:43.6

of San Francisco. Welcome back. Hey, thanks for having me. Nice to have you. This vaccine has been

0:49.6

tested in people and passed through phase one trial. So please, tell us what that means. So what that means

0:56.3

is that the vaccine was tested on a small group. In this case, it was 45 people of different ages.

1:02.8

And it showed that it is not only safe, it's not causing any disastrous side effects, but it's also

1:09.6

efficacious. It's creating antibodies in the

1:13.8

people who have taken it. So that means that Moderna is hoping to quickly move into a phase three

1:21.8

trial. And that means that it'll be a much bigger trial on lots of people and hoping to find out that it

1:29.9

works once we have a bigger population taking it.

1:33.9

Are they skipping phase two going right to phase three?

1:38.0

So oftentimes phase one and two get kind of squished together.

1:43.4

And so what we're seeing here is a speeded up version of

1:47.9

a typical set of trials. So phase one and two are designed to determine, as I said, safety and

1:55.6

efficaciousness. And so now in phase three, we try to see how it fares in a big population. They're hoping to have that

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from Science Friday and WNYC Studios, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Science Friday and WNYC Studios and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2026.